The NIH pharmacology review on semaglutide safety data shows that FDA-approved products are subject to strict clinical trials and manufacturing controls
In interviews with Calibrates chief executive Rob MacNaughton and Dr
If your BMI is just under the threshold, the addition of HRT for documented hormonal deficiency may support your case for GLP-1 prescription
Patients should not assume that: Every GLP-1 medication has the same cardiovascular outcome evidence Every patient taking a GLP-1 medication is receiving heart-disease treatment Weight loss automatically means all heart risk is resolved Medication can replace blood pressure, cholesterol, or diabetes care Rapid weight loss is always better A lower scale weight is more important than muscle, strength, and labs Side effects should be ignored if weight loss is happening The safest interpretation is more balanced
Do not double dose
Jung S, Whiteaker JR, Zhao L, Yoo HW, Paulovich AG, Hahn SH